INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/02/2025 ,inter alia, to consider and approve the unaudited financial results (Standalone and Consolidated) of the company for the quarter and nine months ended 31-12-2024 and any other business. A Board meeting for considering the said financial results was conducted on 14-02-2025 for which due intimation was given on 10-02-2025. That Board meeting could not consider said financial results since the financial statements of the material subsidiaries could not be consolidated due to unforeseen circumstances. The said financial results is being considered at an adjourned meeting to be held on 27-02-2024. While giving this intimation to Stock Exchange there is no provision to choose adjourned meeting in the given descriptions hence we have chosen Board meeting rescheduled in the description. Therefore we request you to kindly take note of the adjourned Board meeting.